Kajsa Sundklev is an associate in our Debt Finance practice in Stockholm and joined White & Case in 2018.
Prior to joining White & Case, Kajsa studied at Stockholm University.
Representation of Oatly in connection with its SEK 1.925 billion sustainability-linked financing provided by a club consisting of several banks and other credit providers.
Representation of Svenska Handelsbanken AB (publ) on the update of its U.S.$20 billion US medium term note (MTN) program and subsequent takedown of U.S.$1,250,000,000 0.625% Senior Preferred Notes due 2023.
Representation of Karo Pharma AB, a portfolio company of the private equity firm EQT, that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products, with the financing of the EUR 58 million acquisition of the remaining European rights to the Pevaryl® brand portfolio from Cilag GmbH International, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Representation of Karo Pharma AB, a portfolio company of the private equity firm EQT that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products, with the financing of the 90 MEUR acquisition of the intimate care and dermatology product portfolio from LEO Pharma. The acquired portfolio included four anti-haemorrhoid products: Sheriproct®, Doloproct®, Neriproct® and Ultraproct® and six dermatology products that are mainly over-the-counter: Ultrabas®, Ultralip®, Ultraphil®, Ultrasicc®, Neribas® and Ultralan®.
Representation of Accent Equity Partners AB and its wholly owned subsidiary AE4 2017 Sweden AB as issuer on the issuance of its up to SEK 500,000,000 senior secured floating rate bonds due 2024. The proceeds from the initial bonds were used to finance the acquisition of Scandinavian Cosmetics Group Holding AB and to refinance its existing debt. Scandinavian Cosmetics is one of the leading companies in sales, marketing and distribution of well-known brands in the Swedish beauty industry.
Representation of Outokumpu Oyj in relation to its new secured EUR 400 million term loan facility arranged by Danske Bank A/S, Swedbank AB (publ), OP Corporate Bank plc, Skandinaviska Enskilda Banken AB (publ) and Nordea Bank Abp.
Representation of Svenska Handelsbanken on the issue of USD500,000,000 Additional Tier 1 Contingent Convertible Notes under its USD50,000,000,000 Euro Medium Term Note Programme. The transaction was listed on Euronext Dublin and the underwriters on the deal included Citigroup, Deutsche Bank, Morgan Stanley, Handelsbanken Capital Markets and UBS Investment Bank.
Representation of EQT on the public cash offer to the shareholders of Karo Pharma.
Representation of BNP Paribas Fortis SA/NV, Coöperatieve Rabobank U.A., trading as Rabobank London, ING Bank N.V., Royal Bank of Canada and Sumitomo Mitsui Banking Corporation Europe Limited, as mandated lead arrangers and bookrunners, on a strategic €400 million syndicated cov-lite financing to Kiwa, a global specialist in testing, inspection and certification (TIC).
Representation of Blomsterboda in connection with the financing of the acquisition of S-Blommor Syd from Stena Adactum. Blomsterboda, owned by Nordic private equity firm Accent, provides flowers and plants to some 550 grocery stores across Sweden through full service shop-in-shop flower concepts.
Representation of FSN Capital in connection with the financing of the acquisition of IT-companies Office IT-Partner, Zetup and Dicom.